Home » Topics » Briefs » Other news to note

Other news to note
RSS

Therapeutic Antibodies seeks London Stock Exchange listing

June 7, 1996

Searle sells shares in Hokuriku

May 24, 1996

Ribonucleotide reductase inhibitor 3-AP in development at Vion

May 17, 1996

SKB's anti-IL-5 MAb in preclinical testing for asthma

May 17, 1996

PDE IV inhibitor SB-207499 in phase II

May 17, 1996

SB-221420 in development for stroke

May 17, 1996

SB-238592: Antiinflammatory neuroprotectant in clinical phase

May 17, 1996

SB-204269 in phase I for epilepsy

May 17, 1996

Receptagen demerger on the table at AGM

May 17, 1996

Hafslund Nycomed demerger approved at AGM

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 31, 2025
Novo Nordisk licenses Lexicon’s preclinical obesity drug in $1B deal
BioWorld Science
As companies continually search for next-generation obesity prospects, one of the leaders in the disease space, Novo Nordisk A/S, has obtained an exclusive...
Corcept looks to NDA following strong phase III ovarian cancer data
BioWorld
Relacorilant, a cortisol modulator from Corcept Therapeutics Inc., produced new and strong phase III results in treating platinum-resistant ovarian cancer. The...
Otsuka submits first BLA to FDA for sibeprenlimab in IgAN
BioWorld
Otsuka Pharmaceutical Development & Commercialization Inc. filed its BLA with the U.S. FDA for sibeprenlimab to treat immunoglobulin A nephropathy (IgAN). The...